AKT1 and cancer: One striking outcome of the IPA predictive analysis was highlighting the overlapped top-most downregulated PD-1/PD-L1 cancer immunotherapy pathway, PI3K-AKT, and protein kinase A signaling pathways in both MMTV-PyVT and PDX mouse tumors following OC-X treatments versus the control group (Figure 4C).